On January 11, 2024, the U.S. Food and Drug Administration (FDA) will host a webinar for industry and other interested stakeholders to discuss the final guidance: Assessing the Credibility of Computational Modeling and Simulation in Medical Device Submissions.
Medical device manufacturers are using computational modeling and simulation (CM&S), also called in silico methods, increasingly to help streamline device development and premarket evaluation. The guidance provides a framework that manufacturers can use in their regulatory submissions to the FDA to show that computational models are credible.
On January 11, 2024, the U.S. Food and Drug Administration (FDA) will host a webinar for industry and other interested stakeholders to discuss the final guidance: Assessing the Credibility of Computational Modeling and Simulation in Medical Device Submissions.
During this webinar, the FDA will:
Registration is not necessary.
Date: January 11, 2024
Time: 1:00 PM - 2:00 PM ET
